Nov 2nd, 2009 - Forbes
WHITEHOUSE STATION, N.J. --
U.S. regulators won't accept drugmaker Merck's application for a new combination cholesterol pill that includes rival Pfizer's Lipitor, the world's top-selling drug.
Merck & Co. disclosed the rare move by the Food and Drug Administration in a regulatory filing on Monday.
The company had said about 2 1/2 years ago that it planned to make and market a cholesterol pill combining Pfizer Inc.'s Lipitor with Zetia, a cholesterol pill Merck jointly sells with partner Schering-Plough Corp.
Related stories:
Merck: FDA won't accept its application for combo cholesterol pill including Pfizer's Lipitor
Nov 2nd, 2009 - ChicagoTribune
TRENTON, N.J. (AP) - U.S. regulators have refused to accept drugmaker Merck & Co.'s application for a new, combination cholesterol pill that includes rival Pfizer's Lipitor...
Lupus drug completes testing, heads to FDA for approval
Nov 2nd, 2009 - Washington Post
Rockville-based Human Genome Sciences Inc. announced on Monday that its experimental Lupus drug has completed its final round of testing at a higher dose and will now be headed to the Food and Drug Administration for approval.
GAO: FDA fails to follow up on unproven drugs
Oct 26th, 2009 - AOL News
WASHINGTON -The Food and Drug Administration has allowed drugs for cancer and other diseases to stay on the market even when follow-up studies showed they didn't extend patients' lives...
"Smart Choices" Food Labeling Program Halts Over FDA Concern
Oct 24th, 2009 - The Huffington Post
(AP) PORTLAND, Ore. - A food industry group is voluntarily halting promotion of its nutrition labeling program after federal regulators said such systems could mislead consumers...Food industry stops promoting "Smart Choices" after FDA says it will tackle misleading labels
Oct 23rd, 2009 - baltimoresun
PORTLAND, Ore. (AP) - A food industry group is voluntarily halting promotion of its nutrition labeling program after federal regulators said such systems may be misleading consumers...
Related videos from YouTube:
6:01Pensacola Fosamax Attorney Merck Defect Drug Lawyer Florida
www.levinlaw.com Fosamax follows Vioxx as the latest dangerous drug that drug company Merck has overpromoted Merck pushed it for prevention of osteoporosis, but it is linked to osteonecrosis of the jaw, a disease that spreads bone death.
1:36First Drug to Treat PKU Approved
FDA has approved the first drug to treat phenylketonuria (PKU), which is a genetic disorder that affects one in about 15 thousand births in the US The drug, called Kuvan (sapropterin dihydrochloride) was developed by BioMarin Pharmaceutical in partnership with Merck ...
5:40HPV Bomb: HPV Virus Does NOT Cause Cancer, HPV Vaccine Does
, some US states have made the vaccine a legal requirement for young girls. For details and sources, visit my blog: Red Pill Reich redpillreich.blogspot.com (HPV Bomb: HPV Virus Does NOT Cause Cancer, HPV Vaccine Does, Feb. 2008) ...
5:26FDA Studying Potential Safety Issues with Several Drugs
FDA has informed the health care community about ongoing safety reviews of several drugs. FDA is doing this as part of its commitment to inform health care professionals and the public about its ongoing drug safety reviews. Because this information is preliminary and there is scientific uncertainty ...
